scholarly article | Q13442814 |
P2093 | author name string | Yu Liang | |
Cheng Zhang | |||
Dong-Qiu Dai | |||
P2860 | cites work | Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease | Q24289344 |
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field | Q24620628 | ||
The Gene Ontology (GO) project in 2006 | Q25257646 | ||
GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle | Q28241629 | ||
Genetic variation in bone morphogenetic protein and colon and rectal cancer | Q30503444 | ||
Epigenetic silencing of protocadherin 10 in colorectal cancer | Q33597607 | ||
Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer | Q33618605 | ||
Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas | Q34170505 | ||
Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers | Q34493610 | ||
MLH1 Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features | Q34650716 | ||
Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger | Q35074567 | ||
A systems biology approach for pathway level analysis | Q36004656 | ||
RET is a potential tumor suppressor gene in colorectal cancer | Q36301488 | ||
Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling | Q36571511 | ||
Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer | Q37121671 | ||
Field Cancerization in Sporadic Colon Cancer. | Q37213553 | ||
Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. | Q37445217 | ||
Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers | Q37729102 | ||
FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer | Q38603133 | ||
Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer | Q38715927 | ||
Arsenic trioxide induces cell cycle arrest and alters DNA methylation patterns of cell cycle regulatory genes in colorectal cancer cells | Q38738920 | ||
GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction | Q39069495 | ||
p73 expression is regulated by ribosomal protein RPL26 through mRNA translation and protein stability | Q39204379 | ||
DNA methylation aberrancies as a guide for surveillance and treatment of human cancers | Q39208639 | ||
DNA methylation as an epigenetic biomarker in colorectal cancer | Q39310872 | ||
Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways | Q39379601 | ||
Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome | Q39540112 | ||
Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer. | Q39662058 | ||
Epigenetic silencing of RELN in gastric cancer. | Q39767945 | ||
Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells | Q39868370 | ||
A Practical Guide to The Cancer Genome Atlas (TCGA). | Q39894314 | ||
BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer | Q41056167 | ||
Identification of Biomarkers for Predicting Lymph Node Metastasis of Stomach Cancer Using Clinical DNA Methylation Data. | Q41688320 | ||
Reduced expression of reelin (RELN) gene is associated with high recurrence rate of hepatocellular carcinoma | Q43902405 | ||
Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer | Q44129766 | ||
Genome-wide DNA methylation analysis of formalin-fixed paraffin embedded colorectal cancer tissue | Q44497822 | ||
DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies | Q46181764 | ||
Pre-45s rRNA promotes colon cancer and is associated with poor survival of CRC patients | Q47160718 | ||
Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma | Q49956187 | ||
Reelin protects from colon pathology by maintaining the intestinal barrier integrity and repressing tumorigenic genes | Q50607427 | ||
Patterns of DNA methylation in individual colonic crypts reveal aging and cancer-related field defects in the morphologically normal mucosa | Q51571157 | ||
TGFβ and IGF1R signaling activate protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells. | Q52337636 | ||
Colon cancer associated transcripts in human cancers. | Q52550577 | ||
Fecal Biomarker for Colorectal Cancer Diagnosis | Q53454288 | ||
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. | Q54232902 | ||
Base excision repair capacity as a determinant of prognosis and therapy response in colon cancer patients | Q57486087 | ||
LncRNA NEAT1 promotes colorectal cancer cell proliferation and migration via regulating glial cell-derived neurotrophic factor by sponging miR-196a-5p | Q58077538 | ||
Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway | Q58613794 | ||
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
promoter methylation accelerates colon cancer cell migration | Q60919968 | ||
Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology | Q62494554 | ||
Molecular Genetics of Colorectal Cancer | Q82521439 | ||
Epigenetic regulation of reelin expression in multiple myeloma | Q89337118 | ||
Genetic and epigenetic alterations of colorectal cancer | Q90842099 | ||
Fusobacterium nucleatum Infection in Colorectal Cancer: Linking Inflammation, DNA Mismatch Repair and Genetic and Epigenetic Alterations | Q90993343 | ||
P4510 | describes a project that uses | limma | Q112236343 |
P433 | issue | 26 | |
P921 | main subject | bioinformatics | Q128570 |
colon cancer | Q18555025 | ||
P304 | page(s) | 3392-3407 | |
P577 | publication date | 2019-07-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis | |
P478 | volume | 25 |
Q92340205 | Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinoma |
Q102323905 | Cysteine metabolic circuitries: druggable targets in cancer |
Q89907445 | SEPSIS. Educational and Best Practice Frontiers. Beyond the Boundaries of Fatality, Enhancing Clinical Skills and Precision Medicine |
Search more.